TFEC (Transcription Factor EC) is a member of the MITF/TFEB/TFE3/TFEC family of basic helix-loop-helix leucine zipper (bHLH-Zip) transcription factors. While TFEB and TFE3 are well-characterized master regulators of autophagy and lysosomal biogenesis, TFEC has distinct expression patterns and functions that make it particularly relevant to neurodegenerative disease research.
Structural Features
TFEC shares structural features with other family members:
Leucine zipper domain: Facilitates dimerization with other bHLH-Zip proteins
Transcriptional Targets
TFEC regulates genes involved in:
Role in Cellular Processes
Lysosomal Biogenesis
TFEC, like its siblings TFEB and TFE3, drives expression of lysosomal and autophagic genes. The Ferreira et al. (2023) study demonstrated that TFEC is the predominant transcription factor controlling lysosomal biogenesis in microglia, with expression patterns distinct from TFEB. [@ferreira2023]
Autophagy Regulation
Through binding to CLEAR elements in target gene promoters, TFEC coordinates the autophagy-lysosome pathway:
Mermaid diagram (expand to render)
Comparison with TFEB and TFE3
Relevance to Neurodegenerative Diseases
Alzheimer's Disease
In AD, TFEC plays important roles through several mechanisms:
Microglial lysosomal function: TFEC maintains lysosomal capacity in disease-associated microglia (DAM), helping clear amyloid-beta and damaged organelles
TREM2 crosstalk: TFEC is directly regulated by TREM2 signaling in microglia. Loss of TREM2 function (protective variant R47H) impairs TFEC-mediated lysosomal biogenesis, contributing to reduced amyloid clearance
Autophagy impairment: In AD microglia, TFEC activity is reduced, leading to accumulation of autophagic vacuoles and impaired protein clearance